UBT-251

peptide · endocrine · digestive · Subcutaneous

UBT-251, a peptide. Investigational peptide agonist of GLP-1, GIP and glucagon receptors, distinct from retatrutide.

Investigational peptide agonist of GLP-1, GIP and glucagon receptors, distinct from retatrutide.

IDENTITY: Vistrutide is a vendor-used name, not an established regulatory designation. PK must not be borrowed from retatrutide. DOSE: PMID:42843337 studied weekly 2, 4, and 6 mg regimens over 24 weeks, including 0.5 or 1 mg initial doses in the 4 mg group. PMID:42712041 reports the SC route; this is not an established dose.

Sources: PMID:42712041, PMID:42843337